IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 6883-6890

  Beyeen, Amennai D ^a   Adzemovic, Milena Z ^a,c   Öckinger, Johan ^a   Stridh, Pernilla ^a   Becanovic, Kristina ^a   Laaksonen, Hannes ^a   Lassmann, Hans ^c   Harris, Robert A ^a   Hillert, Jan ^a   Alfredsson, Lars ^b   Celius, Elisabeth G ^d   Harbo, Hanne F ^e   Kockum, Ingrid ^a   Jagodic, Maja ^a   Olsson, Tomas ^a  

^a Center for Molecular Medicine   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Institute of Basic Medical Sciences   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR ALPHA 2; UNCLASSIFIED DRUG;

ADVANCED INTERCROSS LINE; ALLELE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 1; COHORT ANALYSIS; CONGENIC RESISTANT STRAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; EFFECTOR CELL; FEMALE; GENE; GENETIC RISK; HUMAN; INNATE IMMUNITY; LINKAGE ANALYSIS; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; SINGLE NUCLEOTIDE POLYMORPHISM; SPLEEN CELL;

ANIMALS; ANIMALS, CONGENIC; CROSSES, GENETIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; MACROPHAGES, PERITONEAL; MALE; MULTIPLE SCLEROSIS; RATS; RATS, INBRED STRAINS; RECEPTORS, INTERLEUKIN; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 78650673588     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001392     Document Type: Article

References (54)

1. El Behi, M., S. Dubucquoi, D. Lefranc, H. Zéphir, J. De Seze, P. Vermersch, and L. Prin. 2005. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Lett. 96:11-26.
2. Brück, W., N. Sommermeier, M. Bergmann, U. Zettl, H. H. Goebel, H. A. Kretzschmar, and H. Lassmann. 1996. Macrophages in multiple sclerosis. Immunobiology 195:588-600.
3. Vyse, T. J., and J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85:311-318.
4. Olerup, O., and J. Hillert. 1991. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38:1-15.
5. International Multiple Sclerosis Genetics Consortium, D. A. Hafler, A. Compston, S. Sawcer, E. S. Lander, M. J. Daly, P. L. De Jager, P. I. de Bakker, S. B. Gabriel, D. B. Mirel, A. J. Ivinson, et al. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357:851-862.
6. Hoppenbrouwers, I. A., Y. S. Aulchenko, A. C. Janssens, S. V. Ramagopalan, L. Broer, M. Kayser, G. C. Ebers, B. A. Oostra, C. M. van Duijn, and R. Q. Hintzen. 2009. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. J. Hum. Genet. 54:676-680.
7. Lorentzen, J. C., S. Issazadeh, M. Storch, M. I. Mustafa, H. Lassman, C. Linington, L. Klareskog, and T. Olsson. 1995. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. J. Neuroimmunol. 63:193-205.
8. Storch, M. K., A. Stefferl, U. Brehm, R. Weissert, E. Wallström, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann. 1998. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:681-694.
9. Thessen Hedreul, M., A. Gillett, T. Olsson, M. Jagodic, and R. A. Harris. 2009. Characterization of multiple sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis. J. Neuroimmunol. 210:30-39.
10. Weissert, R., E. Wallström, M. K. Storch, A. Stefferl, J. Lorentzen, H. Lassmann, C. Linington, and T. Olsson. 1998. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 102:1265-1273.
11. Becanovic, K., E. Wallstrom, B. Kornek, A. Glaser, K. W. Broman, I. Dahlman, P. Olofsson, R. Holmdahl, H. Luthman, H. Lassmann, and T. Olsson. 2003. New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 170:1062-1069.
12. Jagodic, M., and T. Olsson. 2006. Combined-cross analysis of genome-wide linkage scans for experimental autoimmune encephalomyelitis in rat. Genomics 88:737-744.
13. Ockinger, J., P. Stridh, A. D. Beyeen, F. Lundmark, M. Seddighzadeh, A. Oturai, P. S. Sørensen, A. R. Lorentzen, E. G. Celius, V. Leppä, et al. 2010. Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis. Genes Immun. 11:142-154.
14. Darvasi, A., and M. Soller. 1995. Advanced intercross lines, an experimental population for fine genetic mapping. Genetics 141:1199-1207.
15. Jagodic, M., C. Colacios, R. Nohra, A. S. Dejean, A. D. Beyeen, M. Khademi, A. Casemayou, L. Lamouroux, C. Duthoit, O. Papapietro, et al. 2009. A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis. Sci. Transl. Med. 1:10ra21.
16. Nohra, R., A. D. Beyeen, J. P. Guo, M. Khademi, E. Sundqvist, M. T. Hedreul, F. Sellebjerg, C. Smestad, A. B. Oturai, H. F. Harbo, et al. 2010. RGMA and IL21R show association with experimental inflammation and multiple sclerosis. Genes Immun. 11:279-293.
17. Swanberg, M., O. Lidman, L. Padyukov, P. Eriksson, E. Akesson, M. Jagodic, A. Lobell, M. Khademi, O. Börjesson, C. M. Lindgren, et al. 2005. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat. Genet. 37:486-494.
18. Wakeland, E., L. Morel, K. Achey, M. Yui, and J. Longmate. 1997. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol. Today 18:472-477.
19. Jagodic, M., K. Becanovic, J. R. Sheng, X. Wu, L. Bäckdahl, J. C. Lorentzen, E. Wallström, and T. Olsson. 2004. An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci. J. Immunol. 173:1366-1373.
20. Amor, S., N. Groome, C. Linington, M. M. Morris, K. Dornmair, M. V. Gardinier, J. M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:4349-4356.
21. Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
22. Wenz, H., J. M. Robertson, S. Menchen, F. Oaks, D. M. Demorest, D. Scheibler, B. B. Rosenblum, C. Wike, D. A. Gilbert, and J. W. Efcavitch. 1998. High-precision genotyping by denaturing capillary electrophoresis. Genome Res. 8:69-80.
23. Polman, C. H., S. C. Reingold, G. Edan, M. Filippi, H. P. Hartung, L. Kappos, F. D. Lublin, L. M. Metz, H. F. McFarland, P. W. O'Connor, et al. 2005. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 58:840-846.
24. Poser, C. M., D. W. Paty, L. Scheinberg, W. I. McDonald, F. A. Davis, G. C. Ebers, K. P. Johnson, W. A. Sibley, D. H. Silberberg, and W. W. Tourtellotte. 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:227-231.
25. Roos, I. M., I. Kockum, and J. Hillert. 2008. The interleukin 23 receptor gene in multiple sclerosis: a case-control study. J. Neuroimmunol. 194:173-180.
26. de Bakker, P. I., R. Yelensky, I. Pe'er, S. B. Gabriel, M. J. Daly, and D. Altshuler. 2005. Efficiency and power in genetic association studies. Nat. Genet. 37:1217-1223.
27. Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
28. Ekelund, E., A. Saaf, M. Tengvall-Linder, E. Melen, J. Link, J. Barker, N. J. Reynolds, S. J. Meggitt, J. Kere, C. F. Wahlgren, et al. 2006. Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis. Am. J. Hum. Genet. 78:1060-1065.
29. Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M. A. Ferreira, D. Bender, J. Maller, P. Sklar, P. I. de Bakker, M. J. Daly, and P. C. Sham. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81:559-575.
30. Manichaikul, A., J. Dupuis, S. Sen, and K. W. Broman. 2006. Poor performance of bootstrap confidence intervals for the location of a quantitative trait locus. Genetics 174:481-489.
31. Dahlman, I., L. Jacobsson, A. Glaser, J. C. Lorentzen, M. Andersson, H. Luthman, and T. Olsson. 1999. Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9. J. Immunol. 162:2581-2588. (Pubitemid 29309277)
32. Dahlman, I., E. Wallström, R. Weissert, M. Storch, B. Kornek, L. Jacobsson, C. Linington, H. Luthman, H. Lassmann, and T. Olsson. 1999. Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum. Mol. Genet. 8:2183-2190. (Pubitemid 29525332)
33. Whittington, H. A., L. Armstrong, K. M. Uppington, and A. B. Millar. 2004. Interleukin-22: a potential immunomodulatory molecule in the lung. Am. J. Respir. Cell Mol. Biol. 31:220-226.
34. Dumoutier, L., D. Lejeune, D. Colau, and J. C. Renauld. 2001. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J. Immunol. 166:7090-7095.
35. Kotenko, S. V., L. S. Izotova, O. V. Mirochnitchenko, E. Esterova, H. Dickensheets, R. P. Donnelly, and S. Pestka. 2001. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J. Immunol. 166:7096-7103.
36. Gruenberg, B. H., A. Schoenemeyer, B. Weiss, L. Toschi, S. Kunz, K. Wolk, K. Asadullah, and R. Sabat. 2001. A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta. Genes Immun. 2:329-334.
37. Wu, P. W., J. Li, S. R. Kodangattil, D. P. Luxenberg, F. Bennett, M. Martino, M. Collins, K. Dunussi-Joannopoulos, D. S. Gill, N. M. Wolfman, and L. A. Fouser. 2008. IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22. J. Mol. Biol. 382:1168-1183.
38. Fernandez-Botran, R., F. A. Crespo, and X. Sun. 2002. Soluble cytokine receptors in biological therapy. Expert Opin. Biol. Ther. 2:585-605.
39. Hale, K. K., C. G. Smith, S. L. Baker, R. W. Vanderslice, C. H. Squires, T. M. Gleason, K. K. Tucker, T. Kohno, and D. A. Russell. 1995. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Cytokine 7:26-38.
40. Sato, T. A., M. B. Widmer, F. D. Finkelman, H. Madani, C. A. Jacobs, K. H. Grabstein, and C. R. Maliszewski. 1993. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 150:2717-2723.
41. Levillayer, F., M. Mas, F. Levi-Acobas, M. Brahic, and J. F. Bureau. 2007. Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virusinduced neurological diseases. Genetics 176:1835-1844.
42. Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa, K. Kitoh, S. Kim-Mitsuyama, A. Takayanagi, et al. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129:969-984.
43. Ikeuchi, H., T. Kuroiwa, N. Hiramatsu, Y. Kaneko, K. Hiromura, K. Ueki, and Y. Nojima. 2005. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 52:1037-1046.
44. Endam, L. M., Y. Bossé, A. Filali-Mouhim, C. Cormier, P. Boisvert, L. P. Boulet, T. J. Hudson, and M. Desrosiers. 2009. Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis. Otolaryngol. Head Neck Surg. 140:741-747.
45. Kebir, H., K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13:1173-1175.
46. Wolk, K., S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat. 2004. IL-22 increases the innate immunity of tissues. Immunity 21:241-254.
47. Hiraki, K., I. K. Park, K. Kohyama, and Y. Matsumoto. 2009. Characterization of CD8-positive macrophages infiltrating the central nervous system of rats with chronic autoimmune encephalomyelitis. J. Neurosci. Res. 87:1175-1184.
48. Andersson, A., R. Kokkola, J. Wefer, H. Erlandsson-Harris, and R. A. Harris. 2004. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. J. Leukoc. Biol. 76:1118-1124.
49. Seamons, A., A. Perchellet, and J. Goverman. 2006. Endogenous myelin basic protein is presented in the periphery by both dendritic cells and resting B cells with different functional consequences. J. Immunol. 177:2097-2106.
50. Kelley, J., B. de Bono, and J. Trowsdale. 2005. IRIS: a database surveying known human immune system genes. Genomics 85:503-511.
51. Rubio, J. P., J. Stankovich, J. Field, N. Tubridy, M. Marriott, C. Chapman, M. Bahlo, D. Perera, L. J. Johnson, B. D. Tait, et al. 2008. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun. 9:624-630.
52. Moreland, L. W. 1999. Clinical and pharmacological experience with etanercept. Expert Opin. Investig. Drugs 8:1443-1451.
53. Wacholder, S., S. Chanock, M. Garcia-Closas, L. El Ghormli, and N. Rothman. 2004. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 96:434-442.
54. Purcell, S., S. S. Cherny, and P. C. Sham. 2003. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150.